ロード中...
Allogeneic FLT3 CAR T Cells with an Off-Switch Exhibit Potent Activity against AML and Can Be Depleted to Expedite Bone Marrow Recovery
Patients with relapsed or refractory acute myeloid leukemia (AML) have a dismal prognosis and limited treatment options. Chimeric antigen receptor (CAR) T cells have achieved unprecedented clinical responses in patients with B cell leukemias and lymphomas and could prove highly efficacious in AML. H...
保存先:
| 出版年: | Mol Ther |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Gene & Cell Therapy
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7544976/ https://ncbi.nlm.nih.gov/pubmed/32592688 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2020.06.022 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|